Medical Communications

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …

Bristol-Myers Squibb announced that it has received the first and only European approval for a PD1 inhibitor in the treatment …

NICE has performed a U-turn on Celgene’s Imnovid (pomalidomide) based on new data and the offer of a price reduction. …

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …

Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …

A team of biomedical engineering researches, who performed their study at the University of Arkansas, have identified a drug that …